IBRX
Immunitybio Inc
8.50$
+0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -63.2% | -81.4% | +2.3% | +4.4% | -8.5% | +1,307.0% | +54.4% | -74.3% | +159.2% | +2,270.6% | +668.3% | |
| – | – | – | – | – | – | +1.5% | – | – | -23.5% | -5.2% | -95.7% | |
| – | -63.2% | -81.4% | +2.3% | +6,915.6% | -384.1% | – | +54.4% | -74.3% | +159.2% | +2,270.6% | +663.2% | |
| – | +616.9% | +132.2% | +49.8% | +34.3% | -8.5% | +185.4% | +40.5% | +26.6% | -6.4% | -18.2% | +9.3% | |
| – | +5,163.0% | -58.1% | -40.1% | -50.3% | -36.4% | +50.9% | +396.3% | -24.1% | +19.5% | +37.5% | -11.1% | |
| – | +3,913.5% | -49.1% | -22.6% | -5.0% | -34.8% | +282.3% | +49.5% | +6.1% | +3.2% | -1.1% | +2.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +836.4% | -29.9% | +1,267.2% | +53.3% | +63.6% | +217.5% | +83.9% | +51.8% | -14.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30,200.0% | – | – | – | – | – | – | +277.8% | -217.6% | – | -266.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.